Indonesia Receives Additional 313,100 Doses Of AstraZeneca Vaccine Again

Illustration of giving vaccines (doc. Antara)

JAKARTA - Indonesia will again receive an additional 313,100 doses of COVID-19 vaccine from AstraZeneca. This means that Indonesia has received a total of 92.2 million doses of COVID-19 vaccine in the form of ready-made vaccines and vaccine raw materials.

"The arrival of the AstraZeneca vaccine from the Covax Facility cannot be separated from the hard work of the Government of Indonesia, which since October 2020 has been exploring Covax's multilateral COVID-19 cooperation, a global initiative aimed at equal access to COVID-19 vaccine," a spokesperson for COVID-19 Vaccination said. Siti Nadia Tarmizi, as quoted from Antara, Sunday, June 6.

He stated that the availability of vaccines is very crucial in accelerating the implementation of the national vaccination program. According to him, Indonesia has received a total of three million doses of ready-made vaccines from Sinovac, as many as 6.7 million doses of ready-made vaccines from AstraZeneca, one million doses of ready-made vaccines from Sinopharm, and 81.5 million doses of raw materials for vaccines from Sinovac.

"Through the GAVI Covax Advance Market Commitment mechanism, Indonesia gets a COVID-19 vaccine quota of three to 20 percent of the population," he continued.

The government continues to strive to improve vaccination services so that they can reach an average of one million citizens per day starting in June 2021 in order to accelerate the realization of group immunity against COVID-19.

The government has vaccinated human resources in the health sector, public service sector workers, and the elderly and has started to vaccinate people aged 50 years and over.

As of June 4, 2021, the number of residents who have received the first injection of the COVID-19 vaccine is 17.3 million people and the number of residents who have finished undergoing vaccination or have received two vaccine injections is recorded at 11.1 million people.

The Mutual Cooperation Vaccination Program has also been running and until May 30, 2021, it has reached 49 thousand workers from 36 business entities or legal entities.